Last reviewed · How we verify
NCT07069114
Prognostic Factors for ACDF With BAK/C in Cervical Disc Disease
trial testing Anterior Cervical Discectomy and Fusion with BAK/C Interbody Fusion in Cervical Spondylosis in 80 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | Liang Hao |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Anterior Cervical Discectomy and Fusion with BAK/C Interbody Fusion
Conditions studied
- Cervical Spondylosis — all drugs for Cervical Spondylosis →
Sponsor
Liang Hao
Who can join
Adults 36 to 75, any sex, with Cervical Spondylosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective study aimed to identify predictive prognostic factors for treatment outcomes in patients with cervical degenerative disc disease (CDDD). The study analyzed data from 80 patients who underwent anterior cervical discectomy and fusion (ACDF) with the Bagby and Kuslich (BAK/C) technique. Patients were stratified into two groups based on clinical outcomes at a 3-year follow-up, and logistic regression was used to determine which factors, such as age and bone mineral density, were independent predictors of poor recovery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07069114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Spondylosis
Currently open trials in the same condition.
- NCT06093997 — Study on the Treatment of C/S of Qi Stagnation and Blood-stasis Type by Moving Cupping with Bloodletting · NA · recruiting
- NCT04623593 — Cervical Arthroplasty Cost Effectiveness Study (CACES) · NA · recruiting
- NCT03320759 — Enhancing Recovery in Non-Traumatic Spinal Cord Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07069114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liang Hao
- Last refreshed: 16 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07069114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing